石四药集团：比拉斯汀及匹可硫酸钠获国家药监局批准登记成为在上市制剂使用的原料药

Core Viewpoint - The company Shijiazhuang Yiling Pharmaceutical Group (stock code: 02005) has received approval from the National Medical Products Administration of China for its active pharmaceutical ingredients Bilastine and Picoplatin Sodium to be used in marketed formulations [1] Group 1 - Bilastine is primarily used for the symptomatic treatment of urticaria [1] - Picoplatin Sodium is mainly used for bowel cleansing prior to surgical procedures such as colonoscopy [1]